MMedication Read More Drivers on 4 prescriptions issued road ‘ban’ warningFebruary 19, 2026 Individuals taking four types of prescription medications could be “banned” from the roads, with painkillers and sleeping drugs…
MMedication Read More Ozempic for Drinking: Approved Drugs for Alcohol Addiction Are IgnoredFebruary 19, 2026 To some extent, Americans are talking about alcohol more than ever. We’re having open conversations about the negative…
MMedication Read More NHS must keep medicine rebate down or lose investmentFebruary 19, 2026 Wednesday 18 February 2026 2:27 pm | Updated: Wednesday 18 February 2026 3:10 pm Share Facebook Share on Facebook…
MMedication Read More FDA will drop two-study requirement for new drug approvals, aiming to speed access :: WRAL.comFebruary 19, 2026 WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
MMedication Read More Patient associations complain over drug price hikesFebruary 19, 2026 Cyprus’ patient associations have called for a dialogue on revised categories of drugs, which resulted in higher prices…
MMedication Read More All medication users warned to avoid ‘dangerous’ error when taking tabletsFebruary 19, 2026 A pharmacist has warned all medication users to avoid making a major error when taking tablets. Pharmacist Anum…
MMedication Read More The ‘Mounjaro gap’: How weight-loss drugs are deepening the class divideFebruary 19, 2026 When Kelly Todd, 46, entered secondary care for weight management on the NHS four years ago, she quickly…
MMedication Read More Telangana High Court Quashes Case For Want Of Complaint U/S 54 NMC ActFebruary 19, 2026 The Telangana High Court has held that a Homoeopathy medical practitioner cannot prescribe Allopathy medicines, reiterating the position…
MMedication Read More FDA will drop two-study requirement for new drug approvals, aiming to speed accessFebruary 19, 2026 WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
MMedication Read More Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweightFebruary 19, 2026 At 36 weeks in the TOGETHER-PsO study, concomitant Taltz and Zepbound met primary endpoint of superiority vs. Taltz monotherapy…
MMedication Read More ‘I thought I was going to die as weight-loss jab made me throw up blood’February 19, 2026 Emma, 40, was left collapsed on the bathroom floor unable to lift her own headNeil Shaw Assistant Editor…
MMedication Read More FDA will drop two-study requirement for new drug approvals, aiming to speed accessFebruary 19, 2026 WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…